ARWR
NASDAQ · Biotechnology
Arrowhead Pharmaceuticals In
$87.65
+1.82 (+2.12%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+39.30%
1Y
+409.30%
YTD
+29.30%
Open$88.00
Previous Close$85.83
Day High$88.67
Day Low$86.48
52W High$95.49
52W Low$15.01
Volume—
Avg Volume1.69M
Market Cap12.29B
P/E Ratio—
EPS$-2.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$66.84
Above
SMA 200
$36.65
Above
RSI (14)
36.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
-20.7% upside
Current
$87.65
$87.65
Target
$69.50
$69.50
$62.98
$69.50 avg
$88.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 869.39M | 577.59M | 3.64B |
| Net Income | -1,710,426 | -1,022,710 | -138,687,526 |
| Profit Margin | -0.2% | -0.2% | -3.8% |
| EBITDA | 128.16M | 80.88M | -183,881,108 |
| Free Cash Flow | — | — | -98,110,953 |
| Rev Growth | +50.5% | +50.5% | +9.5% |
| Debt/Equity | 1.34 | 1.34 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |